We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
A pair of Korean biotechs have teamed up to buy stem cell manufacturing facilities and other assets of a failed U.S. biotech to establish a foothold in the U.S.